Skip to main content

Table 1 Evolution of consumption in DID of the different families of antiasthmatic drugs

From: Trends in the use of antiasthmatic medications in Morocco (1999–2010)

  1999 2006 2010
  DID % DID % DID %
Short-acting inhaled Beta-2-mimetic 1.95 48.87 3.46 51.18 4 27.64
Long-acting inhaled Beta-2-mimetic 0.03 0.76 0.07 1.03 0.04 0.48
Systemic Beta-2-mimetic 0.27 6.9 0.33 0.33 0.35 2.42
Inhaled Glucocorticosteroids alone 0.71 18.15 1.11 16.42 1.13 7.81
Association Beta-2-mimetic /Glucocorticosteroids ----- ------ 1.32 19.53 8.53 58.95
Injectable Xanthines 0.95 24.30 0.47 6.95 0.39 2.70
  Σ = 3.91 100% Σ = 6.76 100% Σ = 14.47 100%
  1. DID: D DD/1000 I nhabitants /D ay.